Month: January 2018

What are the key IP issues at the time of selling a startup?

Intellectual property issues can be critical at the time a startup is considering a sale. In this video, partner Tim Harris explains several reasons why an acquirer will scrutinize a startup’s intellectual property before moving forward with a purchase.

Patent and FDA Considerations for Life Sciences Startups

Careful IP planning is especially important in the life sciences, in which companies often rely on only a handful of patents to protect a high-market value product such as an FDA-approved drug. In this article, MoFo counsel Lisa Silverman details the importance of patent protection for life sciences companies, highlighting the long-term benefits of patent term extension and how to identify which assets to prioritize.

Originally appearing in the Daily Journal, read the article here.